What is the implied IZEA (IZEA) share price used for this director stock grant?

The grant uses an implied share price of $3.5100 based on IZEA’s closing market price on March 31, 2026. That price was applied to 4,274 restricted shares to determine a $15,000 value for Q1 2026 director fee compensation.

Director at IZEA (NASDAQ: IZEA) receives $15,000 in restricted stock

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Brady Brian W reported acquisition or exercise transactions in this Form 4 filing.

IZEA Worldwide, Inc. director Brian W. Brady received a grant of 4,274 shares of Common Stock as restricted stock for Q1 2026 director fees. The award was valued at $15,000 based on a closing market price of $3.5100 per share on March 31, 2026, and vested immediately on the grant date. Following this compensation-related grant, Brady directly holds 460,719 shares of IZEA common stock.

Insider Trade Summary 10b5-1

1 transaction reported

Mixed 1 txn

Insider Brady Brian W

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	4,274	$0.00	--

Holdings After Transaction: Common Stock — 460,719 shares (Direct)

Footnotes (1)

[object Object]

Key Figures

Restricted shares granted: 4,274 shares Grant value: $15,000 Reference share price: $3.5100 per share +1 more

4 metrics

Restricted shares granted 4,274 shares Q1 2026 director fees stock award

Grant value $15,000 Value of restricted stock for Q1 2026 director fees

Reference share price $3.5100 per share Closing market price on March 31, 2026 used for valuation

Shares owned after grant 460,719 shares Director’s direct IZEA common stock holdings post-transaction

Key Terms

Restricted Stock, director fees, closing market price, grant date, +1 more

5 terms

Restricted Stock financial

"Restricted Stock received for Q1 2026 director fees valued at $15,000"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

director fees financial

"Restricted Stock received for Q1 2026 director fees valued at $15,000"

closing market price financial

"valued at $15,000 based on the closing market price of $3.5100"

grant date financial

"on the grant date of March 31, 2026. Award vests immediately"

The grant date is the day a company formally gives an employee or contractor the right to receive stock-based compensation, such as stock options or restricted shares. It matters to investors because it fixes key terms—like the price, the start of the ownership clock, and when the award will affect the company’s financial statements and share count—so it can influence dilution, reported expenses, and potential future selling pressure.

vests immediately financial

"Award vests immediately at the grant date."

Form 4 Insider Transactions: What Each Field Means →

04/01/2026 - 04:05 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Brady Brian W

(Last)

(First)

(Middle)

1317 EDGEWATER DR #1880

(Street)

ORLANDO

FLORIDA

32804

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
IZEA Worldwide, Inc. [ IZEA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	03/31/2026		A		4,274⁽¹⁾	A	$0	460,719	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Restricted Stock received for Q1 2026 director fees valued at $15,000 based on the closing market price of $3.5100 on the grant date of March 31, 2026. Award vests immediately at the grant date.

Remarks:

	By: /s/ Peter J. Biere as attorney-in-fact for Brian Brady	04/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did IZEA (IZEA) director Brian W. Brady report in this Form 4?

Brian W. Brady reported receiving 4,274 shares of IZEA common stock as restricted stock. The grant represents Q1 2026 director fees valued at $15,000, based on a $3.5100 closing market price on March 31, 2026, and vested immediately.

How many IZEA (IZEA) shares did the director receive and at what value?

The director received 4,274 restricted shares valued at $15,000 in total. This value was calculated using IZEA’s $3.5100 closing market price on March 31, 2026, as stated in the compensation-related footnote for Q1 2026 director fees.

Is the IZEA (IZEA) Form 4 transaction a market purchase or compensation grant?

The Form 4 reflects a compensation grant, not a market purchase. Brian W. Brady received 4,274 restricted shares for Q1 2026 director fees, valued at $15,000, with no cash price paid per share and immediate vesting on the grant date.

How many IZEA (IZEA) shares does Brian W. Brady hold after this grant?

After the restricted stock grant, Brian W. Brady directly holds 460,719 IZEA common shares. This total reflects his position following the acquisition of 4,274 restricted shares awarded as Q1 2026 director fees that vested immediately at the grant date.

Does the IZEA (IZEA) director restricted stock award vest over time?

No, the restricted stock award vests immediately. The footnote states the 4,274 shares granted for Q1 2026 director fees vested at the March 31, 2026 grant date, meaning the director’s rights to these shares were fully earned right away.